HEALTH

LifeVantage retracts misleading press release

BY Michael Johnsen

SAN DIEGO LifeVantage Corp. on Friday retracted a March 24 press release that likened its Protandim dietary supplement to a “fountain of youth,” stating that the release was unauthorized and not approved by the company or any of its officers.

“We would like to emphasize to our customer and shareholder base that the information included in the news release dated March 24, 2009 distributed via PRWeb, was released by an unauthorized source and contained errors and misrepresentations that shareholders and others should not rely upon,” stated David Brown, LifeVantage president and CEO. “The company takes no responsibility for the contents, and LifeVantage felt it necessary to set the record straight.”

LifeVantage did not specify what the errors or misrepresentations were, however, the retracted press release stated that, “Protandim works differently than other antioxidant supplements. [It] actually signals the cells in your body to produce its own antioxidants enzymes, which provide thousands of times more antioxidant power than any food or conventional supplements. And the proof can be measured precisely through blood tests.”

Other claims in the original press release, which may have run afoul of structure-function language mandated by the Food and Drug Administration in marketing dietary supplements, included: “Protandim is the only clinically proven treatment to dramatically lower oxidative stress to the level of a very young person … If we can tip the balance we may be able to reduce the bad effects of aging like emphysema, heart disease, cancer, strokes, diabetes and hundreds of other diseases associated with aging.”

According to the company’s Web site, Protandim is distributed through GNC.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

New research investigates the aging of populations and its influence on markets

BY Michael Johnsen

LONDON New research released by Datamonitor on Friday identified the aging of populations around the globe and how this trend will have crucial implications for the U.K. markets.

“The aging of populations globally is an issue that will increasingly shape both society and its consumer markets,’ stated Matthew Adams, consumer analyst at Datamonitor and co-author of the reports.

A large proportion of the population in each European country accounted for by consumers aged 50 and above. The U.K. was one of the youngest nations, relatively, in Europe in 2007, but the senior population still exceeded one third of the overall population. The greatest proportional growth in senior is expected to occur in the United States, with a 1.5% compound annual growth rate among seniors.

However, the relative proportion lags behind the norm in Europe by a short margin. In absolute numbers, the senior group of consumers comprises more than 90 million Europeans and should rise to over 100 million by 2012.

Overall, seniors are an ideal target demographic, the report concluded.

“With substantial assets and significant liquid capital, seniors are likely to ‘upgrade’ and choose premium products, particularly those ‘empty nesters’ who have less obligation to support the family and children,” stated Matthew Taylor, consumer market analyst at Datamonitor and also co-author. “The recent ‘less is more’ philosophy might reinforce the pursuit of high quality products. The aging of the baby boomers is also a factor in turning toward a less materialistic approach to the luxury lifestyle. With increased consumer awareness of ‘sustainability’, many products made with natural ingredients cultivated organically, or sourced from specific origins, are becoming popular among these sophisticated consumers.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Alison Sweeney teams up with the APhA to help fellow allergy sufferers find relief

BY Michael Johnsen

WASHINGTON The American Pharmacists Association and McNeil Consumer Healthcare Division on Thursday teamed with actress Alison Sweeney on the launch Behind the Counter Counts, a campaign designed to inform nasal congestion sufferers about pseudoephedrine treatment options located behind the pharmacy counter.

The new campaign features an online resource, www.BTCcenter.com, that features Sweeney’s personal tips, a tool to help people figure out if allergies or colds are causing their nasal congestion, and general information about PSE products.

“Congestion and other allergy symptoms can really get in the way when you’re juggling work, family and everyday life,” Sweeney stated. “I initially didn’t realize the medicines that I’ve relied on, Sudafed and Zyrtec-D … were located behind the pharmacy counter until I spoke with my pharmacist. That’s why I hope other allergy sufferers will do the same, because knowing what’s available and where to find it is the first step to finding the medicine that’s right for you.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?